SemBioSys patents vaccine production tech
Canada's SemBioSys Genetics has been granted a US patent on a vaccine production system that uses genetically modified seeds as biological factories of vaccine antigens.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs